Charles Murchison

3.9k total citations · 1 hit paper
77 papers, 2.7k citations indexed

About

Charles Murchison is a scholar working on Neurology, Pathology and Forensic Medicine and Physiology. According to data from OpenAlex, Charles Murchison has authored 77 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Neurology, 13 papers in Pathology and Forensic Medicine and 12 papers in Physiology. Recurrent topics in Charles Murchison's work include Multiple Sclerosis Research Studies (10 papers), Amyotrophic Lateral Sclerosis Research (7 papers) and Alzheimer's disease research and treatments (7 papers). Charles Murchison is often cited by papers focused on Multiple Sclerosis Research Studies (10 papers), Amyotrophic Lateral Sclerosis Research (7 papers) and Alzheimer's disease research and treatments (7 papers). Charles Murchison collaborates with scholars based in United States, Canada and Australia. Charles Murchison's co-authors include Joseph F. Quinn, Jeffrey Kaye, Matthew Simon, Jeffrey J. Iliff, Dennis Bourdette, Steven Thomas, Ming Ouyang, Weiping Zhang, Xiaoyan Zhang and Randall L. Woltjer and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Neuroscience.

In The Last Decade

Charles Murchison

76 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Association of Perivascular Localization of Aquaporin-4 With Cognition and Alzheimer Disease in Aging Brains

2016 435 citations Charles Murchison, Joseph F. Quinn et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Charles Murchison United States	26	751	678	470	416	400	77	2.7k
Haşmet Hanağası Türkiye	28	470 0.6×	1.1k 1.6×	717 1.5×	246 0.6×	624 1.6×	120	2.7k
Xia Zhang China	31	716 1.0×	218 0.3×	474 1.0×	351 0.8×	873 2.2×	141	2.9k
Christopher H. Hawkes United Kingdom	26	720 1.0×	2.3k 3.3×	376 0.8×	261 0.6×	399 1.0×	61	3.9k
Başar Bılgıç Türkiye	27	296 0.4×	701 1.0×	670 1.4×	189 0.5×	485 1.2×	136	2.5k
Girolama Alessandra Marfia Italy	30	923 1.2×	1.0k 1.5×	649 1.4×	642 1.5×	693 1.7×	99	3.8k
Il‐Gyu Ko South Korea	26	432 0.6×	229 0.3×	393 0.8×	129 0.3×	436 1.1×	103	2.2k
Kaoru Sakatani Japan	31	511 0.7×	458 0.7×	226 0.5×	120 0.3×	279 0.7×	185	3.4k
G. Arnold Germany	31	720 1.0×	1.6k 2.3×	388 0.8×	297 0.7×	166 0.4×	76	2.8k
Jose‐Alberto Palma United States	31	638 0.8×	1.6k 2.4×	529 1.1×	105 0.3×	271 0.7×	120	3.0k
Oscar U. Scremin United States	28	578 0.8×	446 0.7×	299 0.6×	174 0.4×	463 1.2×	106	2.2k

Countries citing papers authored by Charles Murchison

Since Specialization

Citations

This map shows the geographic impact of Charles Murchison's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles Murchison with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles Murchison more than expected).

Fields of papers citing papers by Charles Murchison

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles Murchison. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles Murchison. The network helps show where Charles Murchison may publish in the future.

Co-authorship network of co-authors of Charles Murchison

This figure shows the co-authorship network connecting the top 25 collaborators of Charles Murchison. A scholar is included among the top collaborators of Charles Murchison based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles Murchison. Charles Murchison is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Snyder, Peter J., Jessica Alber, Charles Murchison, et al.. (2025). Association and multimodal model of retinal and blood-based biomarkers for detection of preclinical Alzheimer’s disease. Alzheimer s Research & Therapy. 17(1). 19–19. 4 indexed citations

Arthur, Edmund, et al.. (2025). Retinal Mid-Peripheral Capillary Free Zones Are Enlarged in Diabetic Patients With No Evidence of Clinical Retinopathy. Translational Vision Science & Technology. 14(7). 10–10.

Murchison, Charles, et al.. (2024). Increased levels of extracellular matrix proteins associated with extracellular vesicles from brains of aged mice. Aging Cell. 24(1). e14359–e14359. 1 indexed citations

Shinto, Lynne, Charles Murchison, Lisa C. Silbert, et al.. (2024). ω-3 PUFA for Secondary Prevention of White Matter Lesions and Neuronal Integrity Breakdown in Older Adults. JAMA Network Open. 7(8). e2426872–e2426872. 7 indexed citations

Payami, Haydeh, et al.. (2023). Population fraction of Parkinson’s disease attributable to preventable risk factors. npj Parkinson s Disease. 9(1). 159–159. 9 indexed citations

Lee, Dong Hwan, Joy N. Tsai, E. Sandra Chocrón, et al.. (2022). Gut- and oral-dysbiosis differentially impact spinal- and bulbar-onset ALS, predicting ALS severity and potentially determining the location of disease onset. BMC Neurology. 22(1). 62–62. 33 indexed citations

Raman, Fabio, Yu-Hua Fang, Charles Murchison, et al.. (2021). Dynamic Amyloid PET: Relationships to ¹⁸F-Flortaucipir Tau PET Measures. Journal of Nuclear Medicine. 63(2). 287–293. 10 indexed citations

Murchison, Charles, Richard Kennedy, Jonathan McConathy, & Erik D. Roberson. (2020). Racial Differences in Alzheimer’s Disease Specialist Encounters Are Associated with Usage of Molecular Imaging and Dementia Medications: An Enterprise-Wide Analysis Using i2b2. Journal of Alzheimer s Disease. 79(2). 543–557. 13 indexed citations

Falardeau, Julie, Gail Marracci, Michele Mass, et al.. (2019). Oral lipoic acid as a treatment for acute optic neuritis: a blinded, placebo controlled randomized trial. Multiple Sclerosis Journal - Experimental Translational and Clinical. 5(2). 2454270161–2454270161. 10 indexed citations

10.

Schenning, Katie J., Charles Murchison, Nora Mattek, Jeffrey Kaye, & Joseph F. Quinn. (2019). Sex and genetic differences in postoperative cognitive dysfunction: a longitudinal cohort analysis. Biology of Sex Differences. 10(1). 14–14. 44 indexed citations

11.

Hiller, Amie, et al.. (2018). Alternating Thalamic Deep Brain Stimulation for Essential Tremor: A Trial to Reduce Habituation. Movement Disorders Clinical Practice. 5(6). 620–626. 19 indexed citations

12.

Hiller, Amie, et al.. (2018). A randomized, controlled pilot study of the effects of vitamin D supplementation on balance in Parkinson's disease: Does age matter?. PLoS ONE. 13(9). e0203637–e0203637. 62 indexed citations

13.

Dimitrova, Alexandra, Charles Murchison, & Barry Oken. (2018). The Case for Local Needling in Successful Randomized Controlled Trials of Peripheral Neuropathy: A Follow-Up Systematic Review. Medical Acupuncture. 30(4). 179–191. 8 indexed citations

14.

Senders, Angela, et al.. (2018). Meals, Mindfulness, & Moving Forward: A feasibility study to a multi‐modal lifestyle approach in early psychosis. Early Intervention in Psychiatry. 13(1). 147–150. 14 indexed citations

15.

Dimitrova, Alexandra, Charles Murchison, & Barry Oken. (2017). Acupuncture for the Treatment of Peripheral Neuropathy: A Systematic Review and Meta-Analysis. The Journal of Alternative and Complementary Medicine. 23(3). 164–179. 111 indexed citations

16.

Fino, Peter C., Robert J. Peterka, Timothy E. Hullar, et al.. (2017). Assessment and rehabilitation of central sensory impairments for balance in mTBI using auditory biofeedback: a randomized clinical trial. BMC Neurology. 17(1). 41–41. 33 indexed citations

17.

Spain, Rebecca, Charles Murchison, Fay B. Horak, Jack H. Simon, & Dennis Bourdette. (2016). Lipoic Acid for Neuroprotection in Secondary Progressive Multiple Sclerosis (P1.373). Neurology. 86(16_supplement). 4 indexed citations

18.

Shinto, Lynne, Gail Marracci, David C. Mohr, et al.. (2016). Omega-3 Fatty Acids for Depression in Multiple Sclerosis: A Randomized Pilot Study. PLoS ONE. 11(1). e0147195–e0147195. 34 indexed citations

19.

Voss, Kellen, Christopher Harris, Martina Ralle, et al.. (2014). Modulation of tau phosphorylation by environmental copper. Translational Neurodegeneration. 3(1). 24–24. 68 indexed citations

20.

Sakaguchi, Ronald L., et al.. (2004). Cure induced stresses and damage in particulate reinforced polymer matrix composites: a review of the scientific literature. Dental Materials. 21(1). 43–46. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact